Absci

Absci is the drug &a; target discovery company harnessing deep learning AI &a; synthetic biology to expand the therapeutic potential of proteins

Business Model:

Revenue: $0

Employees: 51-500

Detailed Absci Information

Geographic Data

Absci headquarters map

Address:

City: Vancouver

State: Washington

Zip:

Country: United States

Financial Info

Stage:

series unknown

Raised Last:

$125M

Raised Total:

$238M

Metrics

3,222,295Website Global Rank

4,888Website Monthly Traffic

Twitter Followers

Description

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com.

Contact Phone:

Contact Email:

Absci went public on 7/21/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/21/2021

IPO Valuation:
$1B

Ticker Symbol:
ABSI

IPO Price:
$16/share

Amount Raised:
$200M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2021 Venture Round $0 Perceptive Advisors
D1 Capital Partners
Fidelity Management and Research Company
aMoon Fund
Irving Investors
Helicase Venture
ArrowMark Partners
Redmile Group
Casdin Capital
Casdin Capital
Redmile Group
Perceptive Advisors
D1 Capital Partners
Fidelity Management and Research Company
aMoon Fund
Irving Investors
Helicase Venture
ArrowMark Partners
Redmile Group
Casdin Capital
Casdin Capital
Redmile Group
1/2019 Series D $0 JSR Corp
KBI Biopharma
JSR Corp
KBI Biopharma
8/2017 Series B 1 - Phoenix Venture Partners
Phoenix Venture Partners
5/2018 Series C $0 AGC
Corporation Ventures
Essential Consultants, LLC
Greenbridge Partners
Oregon Venture Fund
Phoenix Venture Partners
Washington Research Foundation
AGC
Corporation Ventures
Essential Consultants, LLC
Greenbridge Partners
Oregon Venture Fund
Phoenix Venture Partners
Washington Research Foundation
2/2021 Corporate Round 1 - Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
2/2016 Series A 3 $5.1M Phoenix Venture Partners
The R-Group, LLC
Oregon Venture Fund
Phoenix Venture Partners
10/2020 Series E 4 $70M Casdin Capital
Redmile Group
Phoenix Venture Partners
ArrowMark Partners
Casdin Capital
12/2019 Debt Financing $5M
1/2013 Seed Round -
1/2020 Series D $0 JSR Life Sciences
KBI Biopharma
Columbia Ventures
Oregon Venture Fund
Phoenix Venture Partners
WRF Capital
JSR Life Sciences
KBI Biopharma
Columbia Ventures
Oregon Venture Fund
Phoenix Venture Partners
WRF Capital
3/2021 Venture Round 9 $125M Perceptive Advisors
D1 Capital Partners
Fidelity Management and Research Company
aMoon Fund
Irving Investors
Helicase Venture
ArrowMark Partners
Redmile Group
Casdin Capital
Casdin Capital
Redmile Group
Perceptive Advisors
D1 Capital Partners
Fidelity Management and Research Company
aMoon Fund
Irving Investors
Helicase Venture
ArrowMark Partners
Redmile Group
Casdin Capital
Casdin Capital
Redmile Group
2/2021 Corporate Round 1 - Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
1/2020 Series D 6 $10.4M JSR Life Sciences
KBI Biopharma
JSR Life Sciences
KBI Biopharma
1/2019 Series D 2 $10.4M JSR Corp
KBI Biopharma
JSR Corp
KBI Biopharma
5/2018 Series C 7 $12M AGC
AGC
8/2017 Series B 1 - Phoenix Venture Partners
Phoenix Venture Partners
1/2013 Seed Round -
Announced Date Name Price
6/2021 Totient
1/2021 Denovium

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research